legislative Archives - Page 2 of 2

RxDC Reporting Will Bring Changes . . . Here’s What to Know Now

Jonas Leyrer, CEBS

07 Dec 202207 Dec 2022

Late last year, Congress passed the Consolidated Appropriations Act, 2021 (CAA), which contained a provision requiring health care plans to submit Prescription Drug Data Collection (RxDC) reports to CMS. RxDC was made retroactive for 2020 but its implementation was delayed for a […]

Compliance Coronavirus (COVID-19) Employee Benefits Legislative SECURE 2.0 U.S.

What Plan Sponsors Need to Know About SECURE 2.0 in the Senate

Amanda Wilke

30 Nov 202210 Feb 2023

The end-of-year push to pass the bill package known as SECURE 2.0 is underway. SECURE 2.0 is comprised of three separate bills, one in the House of Representatives (House) and two in the Senate, aimed at increasing retirement savings and expanding coverage […]

Employee Benefits Insurance Legislative U.S.

Legal & Legislative Reporter: A Kidney Case

Guest Contributor

22 Sep 202222 Sep 2022

Every month, the International Foundation releases the Legal and Legislative Reporter, a compilation of new employee benefits-related case summaries. Below is a summary we thought you’d be interested in. Content provided by Morgan, Lewis & Bockius LLP. The U.S. Supreme Court reverses and […]

Compliance Employee Benefits Health Care HIPAA Legislative Regulatory U.S.

HIPAA Turns 26: Time to Review New Guidance!

Anne Newhouse

17 Aug 202217 Aug 2022

Maybe the 26th anniversary (coming up on August 21, 2022) of the Health Insurance Portability and Accountability Act (HIPAA) isn’t as noteworthy a milestone year as last year’s 25th, but the act remains in the headlines in 2022. HIPAA, the cornerstone patient […]

Communication Compliance Education Employee Benefits Health Care Human Resources (HR) Legislative Regulatory U.S.

Inflation Reduction Act: 6 Health Care Provisions Plan Sponsors Should Know About

Julie Stich, CEBS

12 Aug 202212 Aug 2022

The U.S. House of Representatives is expected to consider a bill today that will likely reduce the cost of drugs for some Medicare recipients through a new cap on out-of-pocket costs and a provision that would allow the U.S. Department of Health […]